- Home
- GROV vs SER Comparison
GROV vs SER Comparison
Compare GROV & SER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GROV
- SER
- Stock Information
- Founded
- GROV 2016
- SER 2017
- Country
- GROV United States
- SER United States
- Employees
- GROV N/A
- SER N/A
- Industry
- GROV Package Goods/Cosmetics
- SER Biotechnology: Pharmaceutical Preparations
- Sector
- GROV Consumer Discretionary
- SER Health Care
- Exchange
- GROV Nasdaq
- SER Nasdaq
- Market Cap
- GROV 59.0M
- SER 53.5M
- IPO Year
- GROV N/A
- SER 2018
- Fundamental
- Price
- GROV $1.11
- SER N/A
- Analyst Decision
- GROV Buy
- SER Strong Buy
- Analyst Count
- GROV 1
- SER 1
- Target Price
- GROV $2.00
- SER $11.00
- AVG Volume (30 Days)
- GROV 108.3K
- SER 14.6K
- Earning Date
- GROV 05-13-2025
- SER 05-24-2025
- Dividend Yield
- GROV N/A
- SER N/A
- EPS Growth
- GROV N/A
- SER N/A
- EPS
- GROV N/A
- SER N/A
- Revenue
- GROV $203,425,000.00
- SER $56,000.00
- Revenue This Year
- GROV N/A
- SER N/A
- Revenue Next Year
- GROV $6.19
- SER N/A
- P/E Ratio
- GROV N/A
- SER N/A
- Revenue Growth
- GROV N/A
- SER N/A
- 52 Week Low
- GROV $1.02
- SER $3.81
- 52 Week High
- GROV $1.95
- SER $14.57
- Technical
- Relative Strength Index (RSI)
- GROV 30.37
- SER 54.85
- Support Level
- GROV $1.07
- SER $4.98
- Resistance Level
- GROV $1.41
- SER $5.49
- Average True Range (ATR)
- GROV 0.09
- SER 0.38
- MACD
- GROV -0.02
- SER -0.01
- Stochastic Oscillator
- GROV 22.68
- SER 53.28
About GROV Grove Collaborative Holdings Inc.
Grove Collaborative Holdings Inc is engaged in providing consumer products. It offers Cleaning accessories, Home and Pantry, Personal care products, Pets supplements and Other products.
About SER Serina Therapeutics Inc.
Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The Company has one reportable segment relating to the research and development of its POZ platform.